KISQALI vs MEKINIST

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. KISQALI and MEKINIST are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KISQALI	MEKINIST
Rating	70/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	RIBOCICLIB SUCCINATE	TRAMETINIB DIMETHYL SULFOXIDE
Manufacturer	Novartis	Novartis
Dosage forms	Tablet	Powder, Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Breast Neoplasms	Non-Small-Cell Lung Carcinoma, Melanoma

kisqali mekinist

Rating

70/100

Pharmacy pays

—

Type

Active ingredient

RIBOCICLIB SUCCINATE

TRAMETINIB DIMETHYL SULFOXIDE

Manufacturer

Novartis

Dosage forms

Tablet

Powder, Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Breast Neoplasms

Non-Small-Cell Lung Carcinoma, Melanoma

Frequently asked questions

Which is better-rated, Kisqali or Mekinist?

Kisqali and Mekinist are tied at 3.5 out of 5 by our independent rating.

What is the difference between Kisqali and Mekinist?

Kisqali contains Ribociclib Succinate, while Mekinist contains Trametinib Dimethyl Sulfoxide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.